NZ280646A - 4-naphthalenyl (and indenyl)-1h-imidazole derivatives; pharmaceutical compositions - Google Patents

4-naphthalenyl (and indenyl)-1h-imidazole derivatives; pharmaceutical compositions

Info

Publication number
NZ280646A
NZ280646A NZ280646A NZ28064695A NZ280646A NZ 280646 A NZ280646 A NZ 280646A NZ 280646 A NZ280646 A NZ 280646A NZ 28064695 A NZ28064695 A NZ 28064695A NZ 280646 A NZ280646 A NZ 280646A
Authority
NZ
New Zealand
Prior art keywords
imidazole
compound
tetrahydro
imidazol
naphthalenyl
Prior art date
Application number
NZ280646A
Other languages
English (en)
Inventor
Jean-Pierre Geerts
Genevieve Motte
Edmond Differding
Jean-Pierre Henichart
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NZ280646A publication Critical patent/NZ280646A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ280646A 1994-12-14 1995-12-11 4-naphthalenyl (and indenyl)-1h-imidazole derivatives; pharmaceutical compositions NZ280646A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9425211.1A GB9425211D0 (en) 1994-12-14 1994-12-14 Substituted 1H-imidazoles

Publications (1)

Publication Number Publication Date
NZ280646A true NZ280646A (en) 1996-08-27

Family

ID=10765918

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ280646A NZ280646A (en) 1994-12-14 1995-12-11 4-naphthalenyl (and indenyl)-1h-imidazole derivatives; pharmaceutical compositions

Country Status (26)

Country Link
US (1) US5658938A (2)
EP (1) EP0717037A1 (2)
JP (1) JPH08208622A (2)
KR (1) KR960022474A (2)
CN (1) CN1054376C (2)
AR (1) AR002257A1 (2)
AU (1) AU693614B2 (2)
BG (1) BG63043B1 (2)
BR (1) BR9505815A (2)
CA (1) CA2165133A1 (2)
CZ (1) CZ327195A3 (2)
EE (1) EE9500064A (2)
FI (1) FI955927L (2)
GB (1) GB9425211D0 (2)
HU (1) HUT73980A (2)
IL (1) IL116325A (2)
IS (1) IS4311A (2)
MX (1) MX9505063A (2)
NO (1) NO305316B1 (2)
NZ (1) NZ280646A (2)
PL (1) PL311736A1 (2)
RO (1) RO113346B1 (2)
RU (1) RU2156239C2 (2)
SK (1) SK155095A3 (2)
TW (1) TW303362B (2)
ZA (1) ZA9510554B (2)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
ZA981080B (en) 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US20030073850A1 (en) * 1998-08-07 2003-04-17 Altenbach Robert J. 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
AU5846901A (en) 2000-05-08 2001-11-20 Orion Corp New polycyclic indanylimidazoles with alpha2 adrenergic activity
TW200306783A (en) * 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
AU2007209382A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of CNS disorders
AU2007312390B2 (en) * 2006-10-19 2013-03-28 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
JP5167265B2 (ja) * 2006-10-19 2013-03-21 エフ．ホフマン−ラ ロシュ アーゲー 微量アミン関連受容体に親和性を有するアミノメチル−２−イミダゾール
CA2668454A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles
WO2008058867A2 (en) * 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag Substituted 4-imidazoles
ES2364701T3 (es) * 2006-12-13 2011-09-12 F. Hoffmann-La Roche Ag Nuevos 2-imidazoles como ligandos para receptores asociados a aminas trazas.
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
EP2114906B1 (en) 2007-02-02 2014-08-06 F. Hoffmann-La Roche AG 2-aminooxazolines as taar1 ligands for cns disorders
MX2009008777A (es) * 2007-02-13 2009-08-25 Schering Corp Derivados y analogos de cromano como agonistas de los receptores alfa2c adrenergicos funcionalmente selectivos.
WO2008100480A1 (en) * 2007-02-13 2008-08-21 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
EP2125749A2 (en) * 2007-02-13 2009-12-02 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
CA2676944C (en) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
AU2008270444A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
CA2694362A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
CA2695071A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
AU2008285795A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
WO2009105504A2 (en) 2008-02-21 2009-08-27 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
RU2513086C2 (ru) * 2008-07-24 2014-04-20 Ф.Хоффманн-Ля Рош Аг Производные 4,5-дигидро-оксазол-2-ила
EP2323734A1 (en) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
EP2356106A1 (en) 2008-10-07 2011-08-17 Schering Corporation Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US8802673B2 (en) 2011-03-24 2014-08-12 Hoffmann-La Roche Inc Heterocyclic amine derivatives
US9073911B2 (en) 2011-06-09 2015-07-07 Hoffmann-La Roche Inc. Pyrazole derivatives
US9029370B2 (en) 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
JP5872069B2 (ja) 2012-01-12 2016-03-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 微量アミン関連受容体（ｔａａｒ）としての複素環誘導体
RS56747B1 (sr) 2012-09-14 2018-03-30 Hoffmann La Roche Pirazol derivati karboksamida kao taar modulatori za upotrebu u lečenju nekoliko poremećaja, kao što su depresija, dijabetes i parkinsonova bolest
WO2014041106A1 (en) 2012-09-17 2014-03-20 F. Hoffmann-La Roche Ag Triazole carboxamide derivatives
WO2015165085A1 (en) 2014-04-30 2015-11-05 F.Hoffmann-La Roche Ag Morpholin-pyridine derivatives
MX2016016488A (es) 2014-08-27 2017-03-30 Hoffmann La Roche Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar).
MX2016016190A (es) 2014-08-27 2017-03-08 Hoffmann La Roche Derivados de pirazino[2,1-a]isoquinolina sustituida para el tratamiento de trastornos del sistema nervioso central.
WO2017157873A1 (en) 2016-03-17 2017-09-21 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
BR112018068688B1 (pt) * 2016-03-17 2023-02-14 Fmc Corporation Processo para converter enantiômero s em sua forma racêmica, composto e uso do mesmo
CN116496261B (zh) * 2023-03-09 2025-06-27 中国人民解放军军事科学院军事医学研究院 4-(1h)-咪唑类衍生物及其医药用途
CN118684628B (zh) * 2024-05-20 2025-06-17 中国人民解放军军事科学院军事医学研究院 取代二氢茚基咪唑类化合物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048972A (ja) * 1983-08-25 1985-03-16 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
JPH04210680A (ja) * 1990-12-01 1992-07-31 Nissan Chem Ind Ltd イミダゾール誘導体および植物生長調節剤
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles

Also Published As

Publication number Publication date
HUT73980A (en) 1996-10-28
CA2165133A1 (en) 1996-06-15
FI955927A7 (fi) 1996-06-15
BR9505815A (pt) 1998-01-06
EE9500064A (et) 1996-06-17
EP0717037A1 (fr) 1996-06-19
BG63043B1 (bg) 2001-02-28
CZ327195A3 (en) 1996-07-17
NO955034D0 (no) 1995-12-12
KR960022474A (ko) 1996-07-18
AR002257A1 (es) 1998-03-11
IL116325A0 (en) 1996-03-31
IS4311A (is) 1996-06-15
CN1133837A (zh) 1996-10-23
AU693614B2 (en) 1998-07-02
RU2156239C2 (ru) 2000-09-20
MX9505063A (es) 1997-01-31
SK155095A3 (en) 1997-02-05
FI955927A0 (fi) 1995-12-11
PL311736A1 (en) 1996-06-24
JPH08208622A (ja) 1996-08-13
NO305316B1 (no) 1999-05-10
CN1054376C (zh) 2000-07-12
BG100208A (bg) 1996-07-31
TW303362B (2) 1997-04-21
RO113346B1 (ro) 1998-06-30
IL116325A (en) 1999-10-28
HU9503549D0 (en) 1996-02-28
ZA9510554B (en) 1996-06-13
FI955927L (fi) 1996-06-15
GB9425211D0 (en) 1995-02-15
US5658938A (en) 1997-08-19
NO955034L (no) 1996-06-17
AU4036895A (en) 1996-06-20

Similar Documents

Publication Publication Date Title
NZ280646A (en) 4-naphthalenyl (and indenyl)-1h-imidazole derivatives; pharmaceutical compositions
DE2618152C2 (de) Arzneimittel auf der Grundlage von Indolderivaten
FI95128C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten difenyylipropyyliamiinijohdannaisten valmistamiseksi
FI101791B (fi) Menetelmä valmistaa terapeuttisesti aktiivista substituoitua 1-(1H-imi datsol-4-yyli)alkyylibentsamidia
JPH0710853B2 (ja) チアジン（又はオキサジン）誘導体、その製法及びその合成中間体
EP0306440A2 (en) 1-(4-substituted phenyl)-1H-imidazoles as cardiovascular agents
FI91858B (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja
JPH0819064B2 (ja) インダンの新誘導体、それらの製造法及び薬剤としての使用
FI77650C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-amino-1,2,3,4-tetrahydronaftalenderivat.
KR100254690B1 (ko) 트라조돈의 알킬 유도체
CN101282954A (zh) 治疗剂
EP0198235A2 (en) Imidazole derivatives having antimycotic and antibacterial activities, a process for the preparation thereof and pharmaceutical compositions containing them
FI102167B (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen aminoalkyylibent seenijohdannaisten valmistamiseksi
FI70008C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-enyletanolaminderivat
US4288448A (en) N-Substituted imidazole derivatives, and their use
HU195645B (en) Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same
WO1997046555A1 (en) Imidazole-substituted quinoxalinedione derivatives
JP3437695B2 (ja) アゾリルアミン誘導体
US6248907B1 (en) N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine
FI85853C (fi) Foerfarande foer framstaellning av 4- metoxi-2'-/2-(1-metyl-2-piperidyl) etyl/bentsanilidhydroklorid och 1-(2-nitrofenyl)-2-/2-(1-metyl) pyridiniummetylsulfat/etanol.
US5726178A (en) Alkyl derivatives of trazodone with CNS activity
CN107043361A (zh) 治疗心绞痛的化合物、制备方法及用途
HU202861B (en) Process for producing new 1- and 4-substituted 2:2'-bi-1h-imidazol derivatives and pharmaceutical compositions containing them as active components
GB2209748A (en) Imidazolinyl derivatives of dihydronapthalene and tetrahydronapthalene
JPWO1999021839A1 (ja) 複素環化合物及びその用途